Evoq Remedies Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 10/10/2025 ,inter alia, to consider and approve With reference to our earlier ....
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Evoq Remedies has rescheduled its Board of Directors meeting from 9th October 2025 to 10th October 2025 at 4:00 P.M. at its registered office in Ahmedabad, citing unavoidable circumstances. The board will inter alia consider and approve the Unaudited Financial Results for the half year ended 30th September 2025 along with the Limited Review Report. The meeting will also discuss any other matters with the chairperson's permission. Signed by Managing Director Bhumishth Patel.
This is a routine procedural filing with a one-day postponement, unlikely to materially affect the stock. Investors should watch for the half-yearly (H1 FY26) unaudited results announcement expected after tomorrow's board meeting.